(Q48571396)

12 February 2018

title

Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1534178

6 October 2022

main subject

dopamine

0 references

drug-induced akathisia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1534178

6 October 2022

salicylamide

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1534178

6 October 2022

benzazepine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1534178

6 October 2022

author name string

L. Farde

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1534178

6 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1534178

6 October 2022

publication date

1 January 1992

1 reference

12 February 2018

published in

Psychopharmacology

1 reference

12 February 2018

volume

107

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

23-29

1 reference

12 February 2018

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02244961

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02244961

Subjective response to antipsychotic drugs

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02244961

Psychomotility and parkinsonism in treatment with neuroleptic drugs.

21 January 2018

1 reference

12 December 2020

Akathisia variants and tardive dyskinesia

1 reference

12 December 2020

Performance study of the PC-384 positron camera system for emission tomography of the brain

1 reference

12 December 2020

Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

1 reference

12 December 2020

A rating scale for drug-induced akathisia

1 reference

12 December 2020

Neuroleptic-induced akathisia: a review

1 reference

12 December 2020

Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys

1 reference

12 December 2020

Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography

1 reference

12 December 2020

In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors

1 reference

12 December 2020

Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis

1 reference

12 December 2020

Head fixation device for reproducible position alignment in transmission CT and positron emission tomography

1 reference

12 December 2020

Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology

1 reference

12 December 2020

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

12 December 2020

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

1 reference

12 December 2020

Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia

1 reference

12 December 2020

Human dopamine receptor subtypes--in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride

1 reference

12 December 2020

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

12 December 2020

SCH 23390—The first selective dopamine D-1 antagonist

1 reference

12 December 2020

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

1 reference

12 December 2020

Akathisia: the syndrome of motor restlessness

1 reference

12 December 2020

Remoxipride--a new potential antipsychotic drug. Pharmacological effects and pharmacokinetics following repeated oral administration in male volunteers

1 reference

12 December 2020

The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.

1 reference

12 December 2020

Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist

1 reference

12 December 2020

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride

1 reference

12 December 2020

The new selective D2-dopamine receptor antagonist raclopride--pharmacokinetics, safety and tolerability in healthy males

1 reference

12 December 2020

A Comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding

1 reference

12 December 2020

Neuroleptics. Violence as a manifestation of akathisia

1 reference

12 December 2020

Lack of acute antipsychotic effect of Sch 23390, a selective dopamine D1 receptor antagonist

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02244961

1 reference

12 February 2018

1 reference

12 February 2018